Alexis Rossignol

Evidence for <scp>BCR</scp>‐<scp>ABL</scp>‐dependent dysfunctions of i<scp>NKT</scp> cells from chronic myeloid leukemia patients

Alexis Rossignol, Anaïs Levescot, Florence Jacomet et al. · European Journal of Immunology · 2012 · 22 citations

Medicine, Hematology, Immunology +15

A high-performance, non-radioactive potency assay for measuring cytotoxicity: A full substitute of the chromium-release assay targeting the regulatory-compliance objective

Alexis Rossignol, Véronique Bonnaudet, Béatrice Clemenceau et al. · mAbs · 2017 · 21 citations · Full text

Dentistry, Pharmacology, Antibody Engineering +13

The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells

Pauline Estupina, Alexandre Fontayne, Jean‐Marc Barret et al. · Oncotarget · 2017 · 20 citations · Full text

Medicine, Immunology, Oncology +16

The use of impression cytology in the follow-up of severe ocular burns

JJ GICQUEL, R. Navarre, ME LANGMAN et al. · British Journal of Ophthalmology · 2007 · 17 citations · Full text

Medicine, Ophthalmology, Pathology +16

Freshly isolated Vα24+ CD4+ invariant natural killer T cells activated by α-galactosylceramide-pulsed B cells promote both IgG and IgE production

Alexis Rossignol, A Barra, André Herbelin et al. · Clinical & Experimental Immunology · 2007 · 14 citations · Full text

Life Sciences, Cell Biology, Immunology +12